BiotechTube

Ruxolitinib + Prednisone or methylprednisolone

Phase 2Completed
0 watching 0 views this week⚡ Active
49
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Graft-versus-host Disease (GVHD)

Conditions

Graft-versus-host Disease (GVHD)

Trial Timeline

Dec 30, 2016 → Aug 14, 2019

NCT ID
NCT02953678

About Ruxolitinib + Prednisone or methylprednisolone

Ruxolitinib + Prednisone or methylprednisolone is a phase 2 stage product being developed by Incyte for Graft-versus-host Disease (GVHD). The current trial status is completed. This product is registered under clinical trial identifier NCT02953678. Target conditions include Graft-versus-host Disease (GVHD).

Hype Score Breakdown

Clinical
17
Activity
12
Company
7
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02953678Phase 2Completed

Competing Products

20 competing products in Graft-versus-host Disease (GVHD)

See all competitors
ProductCompanyStageHype Score
AlefaceptAstellas PharmaPhase 2
52
EQ001 + EQ001 PlaceboBioconPhase 1/2
41
SHR0302Jiangsu Hengrui MedicinePhase 1
33
Prednisone + Jakavi(ruxolitinib) + PrednisoneNovartisPhase 2
52
PredEverNovartisPhase 2
52
Lifitegrast 5% Ophthalmic Solution + PlaceboNovartisPhase 1
33
LBH589 + MethylprednisoloneNovartisPhase 2
52
Panobinostat (LBH589)NovartisPhase 1/2
41
FilgrastimAmgenPre-clinical
22
AMG 592AmgenPhase 1
32
AMG 592AmgenPhase 1
32
BMS-986004 + Sirolimus + TacrolimusBristol Myers SquibbPhase 1
32
Belumosudil (KD025)SanofiPhase 2
51
Belumosudil 200 mg QD + Belumosudil 200 mg BID + Belumosudil 400 mg QDSanofiPhase 2
51
AAT + PlaceboCSLPhase 2/3
64
Ruxolitinib + MethylprednisoloneIncytePhase 2
49
Tacrolimus (Tac) + Methotrexate (MTX) + Ruxolitinib (Rux) + Cyclophosphamide + Mycophenolate mofetil (MMF)IncytePhase 3
74
Itacitinib + CorticosteroidsIncytePhase 1/2
38
RuxolitinibIncytePre-clinical
20
Itacitinib + CorticosteroidIncytePhase 1
30

Other Products from Incyte

ruxolitinib creamApproved
82
Itacitinib + Placebo + Prednisone + MethylprednisolonePhase 3
74
Povorcitinib + PlaceboPhase 3
74
Ruxolitinib Cream + Vehicle CreamPhase 3
74
Tacrolimus (Tac) + Methotrexate (MTX) + Ruxolitinib (Rux) + Cyclophosphamide + Mycophenolate mofetil (MMF)Phase 3
74